Abstract
Background: Dementia and institutionalization are known long-term complications of stroke, but the extent to which post-stroke disability – as captured by the modified Rankin Scale (mRS) in trials – predicts these outcomes remains unclear. Quantifying this relationship can inform prognostication and cost-effectiveness analyses. Methods: In consecutive 3-month survivors of ischaemic stroke in a population-based prospective cohort (Oxford Vascular Study;2002-2014), we established post-stroke dementia (excluding pre-stroke dementia) and tracked institutionalization (admission to nursing or residential care home) through overlapping methods of cognitive testing and interview-based assessments of patients and carers, and ongoing searches of primary care and hospital records. We related 3-month mRS to 5-year dementia and institutionalization using age/sex-adjusted Cox and logistic regressions (repeated excluding premorbid mRS>2), and compared the area under the receiver operating characteristics curves (AUC) for logistic models versus age/sex alone. Results: Among 1,425 survivors, 3-month mRS independently predicted 5-year dementia and institutionalization whether or not those with premorbid disability were excluded, with mRS of 3-5 carrying higher hazards of each outcome than mRS 0-2; aHR(dementia)=3.37, 95%CI 2.63-4.32, aHR(institutionalization)=6.33, 4.53-8.85, p<0.0001. However, each step up the mRS ladder was associated with a jump in hazard for each outcome; e.g. aHR(dementia) vs mRS=0 for mRS=1: 0.91, 95%CI 0.48-1.75, p=0.78; mRS=2: 1.56, 0.84-2.92, p=0.16; mRS=3: 2.86, 1.54-5.30, p=0.001; mRS=4: 4.61, 2.46-8.63, p<0.0001; mRS=5: 9.79, 5.13-18.7, p<0.0001. Logistic models including the mRS, particularly in its ordinal form, predicted 5-year dementia or institutionalization better than age/sex alone (e.g. AUC for dementia with only age/sex: 0.72, 95%CI 0.69-0.75; with 3-month mRS: 0.79, 0.76-0.82, p<0.0001). Conclusions: 3-month mRS strongly predicts post-stroke dementia and institutionalization, both of which should be considered in cost-effectiveness analyses of acute treatments. The incremental rise in hazard with each step up the mRS ladder further supports using ordinal analysis of the mRS in trials.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have